Beckmann MW - Search Results

1

Common germline polymorphisms associated with breast cancer-specific survival.

Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, Rahman N, Nevanlinna H, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, van Ongeval C, Nordestgaard BG, Nielsen SF, Flyger H, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Olsen JE, Hallberg E, Vachon C, Knight JA, Glendon G, Mulligan AM, Broeks A, Cornelissen S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Butterbach K, Holleczek B, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Manoukian S, Ficarazzi F, Beckmann MW, Hein A, Ekici AB, Balleine R, Phillips KA; kConFab Investigators; Benitez J, Zamora MP, Perez JI, Menéndez P, Jakubowska A, Lubinski … See abstract for full author list ➔ Pirie A, et al. Among authors: beckmann mw. Breast Cancer Res. 2015 Apr 22;17(1):58. doi: 10.1186/s13058-015-0570-7. Breast Cancer Res. 2015. PMID: 25897948 Free PMC article.

2

Aspects of molecular diagnostics and therapy in obstetrics and gynecology.

Beckmann MW, Strick R, Strissel PL, Fasching PA, Oppelt P, Pöhls UD, Malur SU, Ackermann S. Beckmann MW, et al. Expert Rev Mol Diagn. 2003 May;3(3):279-87. doi: 10.1586/14737159.3.3.279. Expert Rev Mol Diagn. 2003. PMID: 12779004 Review.

3

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Krämling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF; Breast Cancer Linkage Consortium. Lakhani SR, et al. Among authors: beckmann mw. Clin Cancer Res. 2005 Jul 15;11(14):5175-80. doi: 10.1158/1078-0432.CCR-04-2424. Clin Cancer Res. 2005. PMID: 16033833

4

Demographic and psychosocial factors associated with risk perception for breast cancer.

Pöhls UG, Fasching PA, Beck H, Kaufmann M, Kiechle M, von Minckwitz G, Paepke S, Schultz-Zehden B, Schwarz-Boeger U, Beckmann MW. Pöhls UG, et al. Among authors: beckmann mw. Oncol Rep. 2005 Dec;14(6):1605-13. Oncol Rep. 2005. PMID: 16273264

5

Hereditary breast and ovarian cancer: review and future perspectives.

Lux MP, Fasching PA, Beckmann MW. Lux MP, et al. Among authors: beckmann mw. J Mol Med (Berl). 2006 Jan;84(1):16-28. doi: 10.1007/s00109-005-0696-7. Epub 2005 Nov 11. J Mol Med (Berl). 2006. PMID: 16283147 Review.

6

Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer.

Lux MP, Ackermann S, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW, Fasching PA. Lux MP, et al. Among authors: beckmann mw. Eur J Cancer Prev. 2005 Dec;14(6):503-11. doi: 10.1097/00008469-200512000-00003. Eur J Cancer Prev. 2005. PMID: 16284494

7

Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.

Glaeser M, Niederacher D, Djahansouzi S, Hanstein B, Dittrich R, Beckmann MW, Fasching PA, Ackermann S. Glaeser M, et al. Among authors: beckmann mw. Anticancer Res. 2006 Jan-Feb;26(1B):735-44. Anticancer Res. 2006. PMID: 16739346 Free article.

8

Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR. Fasching PA, et al. Among authors: beckmann mw. Eur J Radiol. 2006 Dec;60(3):398-404. doi: 10.1016/j.ejrad.2006.08.002. Epub 2006 Oct 9. Eur J Radiol. 2006. PMID: 17030108

9

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.

Fasching PA, von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, Lux MP, Jacobs V, Meden H, Kiechle M, Beckmann MW, Paepke S. Fasching PA, et al. Among authors: beckmann mw. Breast Cancer Res Treat. 2007 Jan;101(1):95-104. doi: 10.1007/s10549-006-9272-2. Epub 2006 Oct 11. Breast Cancer Res Treat. 2007. PMID: 17033928

10

Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.

Ackermann S, Lux MP, Fasching PA, Strissl P, Renner SP, Poehls U, Bender HG, Beckmann MW. Ackermann S, et al. Among authors: beckmann mw. Eur J Cancer Prev. 2006 Dec;15(6):474-9. doi: 10.1097/01.cej.0000220628.62610.ea. Eur J Cancer Prev. 2006. PMID: 17106324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,017 results

Search Page